Growth in Healthcare Jaguar's recent focus on rare disease therapies and pediatric gastrointestinal treatments presents a significant opportunity to engage with healthcare providers, research institutions, and pharmaceutical companies interested in specialized medical solutions.

Regulatory Engagement The company's active discussions with the FDA and efforts to obtain breakthrough therapy designations indicate potential for expansion into regulated markets, creating opportunities for sales of innovative biotech and pharmaceutical products.

Product Diversification Expansion of the Neonorm franchise to include companion animals demonstrates a cross-sector approach, opening avenues to veterinary clinics, pet owners, and animal health product distributors interested in sustainable, plant-based wellness solutions.

Market Positioning Jaguar’s recent stock performance efforts, such as reverse splits and listing extensions, signal ongoing growth and investor interest, which may facilitate strategic partnerships and investment-based sales collaborations with financial and biotech stakeholders.

Technological Adoption The company’s deployment of advanced digital marketing tools and clinical trial success stories highlight its innovative approach, creating opportunities to offer tailored technological solutions and data management services to support their research and commercialization activities.